Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (161-170 of 421) with videos related to

Pageof 43
Sort By:
Breast Cancer Research and Treatment|July 16, 2013
Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC studyMaria Afentakis, Mitch Dowsett, Ivana Sestak, et al.
American Journal of Obstetrics and Gynecology|November 24, 2012
Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV studyJ Thomas Cox, Phillip E Castle, Catherine M Behrens, et al.
Histopathology|February 13, 2023
Measuring cancer burden in prostatic needle core biopsies: simplified assessments outperform complex measurements in assessing outcome: evidence to assist pathologist efficiency and minimize datasetsDaniel M Berney, Kier Finnegan, Kim Chu, et al.
Cancer Medicine|July 19, 2022
A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in EnglandOleg Blyuss, Amanda Dibden, Nathalie J Massat, et al.
British Journal of Cancer|June 22, 2018
Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situLouisa Lisa Lo, Roger Laughlin Milne, Yuyan Liao, et al.
Journal of the National Cancer Institute|September 14, 2013
Factors predicting late recurrence for estrogen receptor-positive breast cancerIvana Sestak, Mitch Dowsett, Lila Zabaglo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor-Positive Lymph Node-Negative Early-Stage Breast CancerIvana Sestak, Yi Zhang, Brock E Schroeder, et al.
Breast Cancer Research : BCR|November 24, 2023
Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: a cohort studyEmma C Atakpa, Diana S M Buist, Erin J Aiello Bowles, et al.
Annals of Neurology|January 25, 2020
Ethnic and Socioeconomic Associations with Multiple Sclerosis RiskRuth Dobson, Mark Jitlal, Charles R Marshall, et al.
Breast Cancer Research and Treatment|March 3, 2021
The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention StudiesSamuel G Smith, Ivana Sestak, Michelle A Morris, et al.
Pageof 43

Showing results (161-170 of 421) with videos related to

Sort By:
Pageof 43
Breast Cancer Research and Treatment|July 16, 2013
Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC studyMaria Afentakis, Mitch Dowsett, Ivana Sestak, et al.
American Journal of Obstetrics and Gynecology|November 24, 2012
Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV studyJ Thomas Cox, Phillip E Castle, Catherine M Behrens, et al.
Histopathology|February 13, 2023
Measuring cancer burden in prostatic needle core biopsies: simplified assessments outperform complex measurements in assessing outcome: evidence to assist pathologist efficiency and minimize datasetsDaniel M Berney, Kier Finnegan, Kim Chu, et al.
Cancer Medicine|July 19, 2022
A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in EnglandOleg Blyuss, Amanda Dibden, Nathalie J Massat, et al.
British Journal of Cancer|June 22, 2018
Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situLouisa Lisa Lo, Roger Laughlin Milne, Yuyan Liao, et al.
Journal of the National Cancer Institute|September 14, 2013
Factors predicting late recurrence for estrogen receptor-positive breast cancerIvana Sestak, Mitch Dowsett, Lila Zabaglo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor-Positive Lymph Node-Negative Early-Stage Breast CancerIvana Sestak, Yi Zhang, Brock E Schroeder, et al.
Breast Cancer Research : BCR|November 24, 2023
Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: a cohort studyEmma C Atakpa, Diana S M Buist, Erin J Aiello Bowles, et al.
Annals of Neurology|January 25, 2020
Ethnic and Socioeconomic Associations with Multiple Sclerosis RiskRuth Dobson, Mark Jitlal, Charles R Marshall, et al.
Breast Cancer Research and Treatment|March 3, 2021
The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention StudiesSamuel G Smith, Ivana Sestak, Michelle A Morris, et al.
Pageof 43